BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. XenoTech specializes in ADME, DMPK and DDI testing of potential drug candidates.   This transaction is part of BioIVT’s continuing commitment to provide its biopharmaceutical customers with a comprehensive portfolio of research models and services to...